Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-180-5 | CAS number: 79-14-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Peer reviewed appraisal of metabolic pathway for glycolic acid pre-cursor and breakdown products of ethylene glycol. The first step in the metabolic pathway of Ethylene Glycol (EG) in mammals involves the conversion of EG to Glycolic acid (GA) via alcohol dehydrogenase. The metabolism of EG to GA has been observed in all species studied, including rats, mice, dogs, rabbits, monkeys, and man. Publication accepted after critical evaluation. This study was selected as the key study because the information provided for the hazard endpoint is sufficient for the purpose of classification and labelling and/or risk assessment.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 971
Materials and methods
- Objective of study:
- distribution
- excretion
- metabolism
- toxicokinetics
- Principles of method if other than guideline:
- The appraisal of ethylene glycol (precursor in metabolic pathway for glycolic acid) metabolism complied with the broad principle of establishing evidence of a metabolic pathway using methods available at the time. The investigations provide a sound basis for further investigation of glycolic acid metabolism and are in broad agreement with the testing principles subsequently established by statute within the EU.
- GLP compliance:
- no
Test material
- Reference substance name:
- Ethane-1,2-diol
- EC Number:
- 203-473-3
- EC Name:
- Ethane-1,2-diol
- Cas Number:
- 107-21-1
- Molecular formula:
- C2H6O2
- IUPAC Name:
- ethylene glycol
- Details on test material:
- - Name of test material (as cited in study report): Ethylene glycol
- Labelling: ~14C (specific activity 780/uc/m-mole)
- Source: Tracerlab, Waltham, Mass.
- Purity: Checked by thin-layer chromaotraphy and found to be homogeneous.
Constituent 1
- Radiolabelling:
- yes
- Remarks:
- 14C labelled
Test animals
- Species:
- other: chimpanzees, rats, and rhesus monkeys
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: male rats 200-290 g; rhesus monkeys 2.2 - 7 kg
- Individual metabolism cages: yes
- Diet (e.g. ad libitum):
- Water (e.g. ad libitum):
Administration / exposure
- Route of administration:
- other: intravenenously and gavage
- Vehicle:
- not specified
- Remarks:
- i.v. doses diluted with saline.
- Duration and frequency of treatment / exposure:
- Once or once followed by a second dose one week later.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
139 mg/kg (intravenously) or 1 mg/kg (gavage)
- No. of animals per sex per dose / concentration:
- 1 - 6
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on distribution in tissues:
- Four hours after an oral dose of 1 mL/kg, tissue and serum concentrations of ethylene glycol in monkeys were approximately 100 mg/100 g, while at 48 hr no measurable ethylene glycol was present. The peak blood level was about 125 mg/100 ml at 1-2 hours.
- Details on excretion:
- Rats and monkeys began excreting 14CO2 in expired air and 14C-labelled compounds in the urine immediately after intravenous administration. Within 24 hours rats had excreted over 60% of the dose by these two routes. In monkeys receiving an equivalent ethylene glycol dose (139 mg/kg), 15% was excreted in urine and expired air within 4 hours. The mean 24-hr urinary excretion in monkeys was 44% of the dose, and 1% was excreted in the next 24 hours. Rats dosed orally excreted a mean of 56% of the 14C in the urine within 24 hr (32% as ethylene glycol). After unchanged ethylene glycol, the next most important urinary excretion product was glycolic acid. In the monkey this accounted for at least 12% of the dose. The output of oxalic acid was quite small in both species, being about 0.3% of the dose in the monkey and about 2.5% in the rat. Between 24 and 48 hours after an oral dose of ethylene glycol, monkeys excreted 0.1% of the dose as hippuric acid.
Toxicokinetic parameters
- Toxicokinetic parameters:
- other: Plasma half-life was 2.7-3.7 hours, depending on the age of the monkeys.
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- After CO2, glycolic acid is the most important metabolite in both the monkey and the rat. Small amounts of oxalic acid and hippuric acid were also excreted.
Applicant's summary and conclusion
- Conclusions:
- Low bioaccumulation potential based on study results
Both rat and monkey began excreting 14CO2 in expired air and 14C-labelled compounds in the urine immediately after intravenous administration. Within 24 hours rats had excreted over 60% of the dose by these two routes; the remainder of the label was distributed widely and uniformly in the tissues. In monkeys receiving an equivalent ethylene glycol dose (139 mg/kg), 15% was excreted in urine and expired air within 4 hours, while the remainder was widely, and generally uniformly, distributed in the tissues. Monkeys readily tolerated oral doses of 1 ml ethylene glycol/kg, the peak blood level being about 125 mg/100 ml at 1-2 hr. The plasma half-life was 2.7-3.7 hr, depending on the age of the monkeys, and the 24-hour excretion as unchanged ethylene glycol amounted to about 22% of the dose; no additional ethylene glycol was excreted in the 24-48 hour period. With 14C-ethylene glycol, the mean 24-hr urinary excretion in monkeys was 44% of the dose, and 1% was excreted in the next 24 hours. Four hours after an oral dose of 1 mL/kg, tissue and serum concentrations of ethylene glycol in monkeys were approximately 100 mg/100 g, while at 48 hours no measurable ethylene glycol was present. Rats receiving the same oral dose in labelled form excreted a mean of 56% of the 14C in the urine within 24 hours (32% as ethylene glycol). After unchanged ethylene glycol, the next most important urinary excretion product was glycolic acid. In the monkey this accounted for at least 12% of the dose. The output of oxalic acid was quite small in both species, being about 0.3% of the dose in the monkey and about 2.5% in the rat. Between 24 and 48 hours after an oral dose of ethylene glycol, monkeys excreted 0.1% of the dose as hippuric acid. - Executive summary:
The metabolism of ethylene glycol was studied rat and rhesus monkey, and in a preliminary study in the chimpanzee, using both unlabelled and 14C-labelled compound. Both rat and monkey began excreting 14CO2 in expired air and 14C-labelled compounds in the urine immediately after intravenous administration. Within 24 hours rats had excreted over 60% of the dose by these two routes; the remainder of the label was distributed widely and uniformly in the tissues. In monkeys receiving an equivalent ethylene glycol dose (139 mg/kg), 15% was excreted in urine and expired air within 4 hours, while the remainder was widely, and generally uniformly, distributed in the tissues. Monkeys readily tolerated oral doses of 1 ml ethylene glycol/kg, the peak blood level being about 125 mg/100 ml at 1-2 hr. The plasma half-life was 2.7-3.7 hr, depending on the age of the monkeys, and the 24-hour excretion as unchanged ethylene glycol amounted to about 22% of the dose; no additional ethylene glycol was excreted in the 24-48 hour period. With 14C-ethylene glycol, the mean 24-hr urinary excretion in monkeys was 44% of the dose, and 1% was excreted in the next 24 hours. Four hours after an oral dose of 1 mL/kg, tissue and serum concentrations of ethylene glycol in monkeys were approximately 100 mg/100 g, while at 48 hours no measurable ethylene glycol was present. Rats receiving the same oral dose in labelled form excreted a mean of 56% of the 14C in the urine within 24 hours (32% as ethylene glycol). After unchanged ethylene glycol, the next most important urinary excretion product was glycolic acid. In the monkey this accounted for at least 12% of the dose. The output of oxalic acid was quite small in both species, being about 0.3% of the dose in the monkey and about 2.5% in the rat. Between 24 and 48 hours after an oral dose of ethylene glycol, monkeys excreted 0.1% of the dose as hippuric acid.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.